Published in Hum Fertil (Camb) on January 01, 2010
Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril (2011) 2.80
The diagnosis of polycystic ovary syndrome: the criteria are insufficiently robust for clinical research. Clin Endocrinol (Oxf) (2007) 2.35
A randomized controlled trial of tubal flushing with lipiodol for unexplained infertility. Fertil Steril (2002) 1.98
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev (2012) 1.76
Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference? Clin Endocrinol (Oxf) (2002) 1.55
The adverse effects of obesity on conception and implantation. Reproduction (2010) 1.50
Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study. Hum Reprod (2005) 1.43
Should obese women with polycystic ovary syndrome receive treatment for infertility? BMJ (2006) 1.34
Non-invasive amino acid turnover predicts human embryo developmental capacity. Hum Reprod (2002) 1.29
UK guidance on the initial evaluation of an infant or an adolescent with a suspected disorder of sex development. Clin Endocrinol (Oxf) (2011) 1.25
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev (2010) 1.21
The use of metformin for women with PCOS undergoing IVF treatment. Hum Reprod (2006) 1.08
Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic. Hum Reprod (2010) 1.06
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev (2009) 1.06
The use of a combination of pentoxifylline and tocopherol in women with a thin endometrium undergoing assisted conception therapies--a report of 20 cases. Hum Fertil (Camb) (2009) 0.95
Defining hyperandrogenism in polycystic ovary syndrome: measurement of testosterone and androstenedione by liquid chromatography-tandem mass spectrometry and analysis by receiver operator characteristic plots. Eur J Endocrinol (2009) 0.94
Conventional ovarian stimulation no longer exists: welcome to the age of individualized ovarian stimulation. Reprod Biomed Online (2011) 0.92
Do South Asian women with PCOS have poorer health-related quality of life than Caucasian women with PCOS? A comparative cross-sectional study. Health Qual Life Outcomes (2010) 0.89
Plasma homocysteine in polycystic ovary syndrome: does it correlate with insulin resistance and ethnicity? Clin Endocrinol (Oxf) (2004) 0.87
Metabolism and karyotype analysis of oocytes from patients with polycystic ovary syndrome. Hum Reprod (2010) 0.86
Health-related quality of life among adolescents with polycystic ovary syndrome. J Obstet Gynecol Neonatal Nurs (2012) 0.83
Polycystic ovary syndrome and its relevance to women from south Asia. Ceylon Med J (2002) 0.81
The association of body mass index and biochemical hyperandrogenaemia in women with and without polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol (2012) 0.78
Associations between common variation in the aromatase gene promoter region and testosterone concentrations in two young female populations. J Steroid Biochem Mol Biol (2006) 0.78
Human embryos developing in vitro are susceptible to impaired epithelial junction biogenesis correlating with abnormal metabolic activity. Hum Reprod (2007) 0.78
Full investigation of patients with polycystic ovary syndrome (PCOS) presenting to four different clinical specialties reveals significant differences and undiagnosed morbidity. Hum Fertil (Camb) (2011) 0.78
Effect of dose escalation of metformin on clinical features, insulin sensitivity and androgen profile in polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol (2011) 0.78
Use of metformin for women with polycystic ovary syndrome. Hum Reprod Update (2012) 0.77
WITHDRAWN: Insulin-sensitising drugs for polycystic ovary syndrome. Cochrane Database Syst Rev (2009) 0.77
Elective cryopreservation of embryos at the pronucleate stage in women at risk of ovarian hyperstimulation syndrome may affect the overall pregnancy rate. Fertil Steril (2006) 0.77
Ethnic variations in the distribution of obesity and biochemical metabolic abnormalities in fertility clinic attendees. J Reprod Med (2008) 0.77
British Fertility Society Policy and Practice Committee: adjuvants in IVF: evidence for good clinical practice. Hum Fertil (Camb) (2014) 0.76
An observational study of women with müllerian agenesis and their need for vaginal dilator therapy. Fertil Steril (2011) 0.75
A woman with polycystic ovary syndrome treated for infertility by in vitro fertilization. Nat Rev Endocrinol (2009) 0.75
Modes of conception and multiple pregnancy: a national survey of babies born during one week in 2003 in the United Kingdom. Fertil Steril (2005) 0.75
British Fertility Society. 'Ovulation induction in WHO Type 1 anovulation: Guidelines for practice'. Produced on behalf of the BFS Policy and Practice Committee. Hum Fertil (Camb) (2013) 0.75
National survey of current practice in assessing tubal patency in the UK. Hum Fertil (Camb) (2004) 0.75
Efficiency. A heavyweight answer to obesity. Health Serv J (2011) 0.75
Management of polycystic ovary syndrome. Womens Health (Lond Engl) (2007) 0.75
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev (2017) 0.75